The role of colloids in intensive care medicine. Evidence instead of emotions

Medizinische Klinik, Intensivmedizin und Notfallmedizin
C S BruellsG Marx

Abstract

Besides albumin, which is gained from human donors, synthetic colloids have been playing a dominant role in treating patients in shock and are standard therapy in intensive care units (ICU). Since the publication of large randomized controlled trials indicating negative effects on renal function, their use has been questioned, especially for hydroxyethyl starch products. The preliminary assumption that these side effects are only existent in first or secondary generation starch fluids was proven incorrect. In fact, the use of hydroxyethyl starch products in critically ill patients is prohibited by the European Medicines Agency. Several methodological limitations exist in each of these trials that limit the evidence value of these investigations, although they served as the basis for the negative judgment of the European Medicines Agency. In addition, a large randomized controlled trial on the efficacy of gelatin is lacking. The use of colloids in ICU patients is indicated in cases where crystalloid volume therapy is inadequate. Especially during the first 6 h of sepsis, when aggressive volume therapy is decisive for patient outcome, colloids may be relevant to increase patient survival. The latest guideline on treatment with co...Continue Reading

References

Oct 26, 2001·JAMA : the Journal of the American Medical Association·B L WarrenUNKNOWN KyberSept Trial Study Group
May 28, 2004·The New England Journal of Medicine·Simon FinferUNKNOWN SAFE Study Investigators
Sep 1, 2007·The New England Journal of Medicine·UNKNOWN SAFE Study InvestigatorsShirley Vallance
Jan 11, 2008·The New England Journal of Medicine·Frank M BrunkhorstUNKNOWN German Competence Network Sepsis (SepNet)
Feb 11, 2012·Intensive Care Medicine·Konrad ReinhartUNKNOWN European Society of Intensive Care Medicine
Jun 29, 2012·The New England Journal of Medicine·Anders PernerUNKNOWN Scandinavian Critical Care Trials Group
Dec 1, 2012·Journal of Neurotrauma·D James CooperUNKNOWN Australian and New Zealand Intensive Care Society Clinical Trials Group
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Feb 22, 2013·The New England Journal of Medicine·Paul Lichtenstein, Henrik Larsson
Feb 22, 2013·The New England Journal of Medicine·Emily ThomasAnthony Liu
Feb 22, 2013·The New England Journal of Medicine·David Cohen
Sep 27, 2013·The New England Journal of Medicine·John A Myburgh, Michael G Mythen
Oct 11, 2013·JAMA : the Journal of the American Medical Association·Djillali AnnaneUNKNOWN CRISTAL Investigators
Mar 19, 2014·The New England Journal of Medicine·Pietro CaironiUNKNOWN ALBIOS Study Investigators
Mar 19, 2014·The New England Journal of Medicine·Donald M YealyDerek C Angus
Oct 2, 2014·Intensive Care Medicine·Mitchell M LevyR Phillip Dellinger
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Oct 3, 2014·Critical Care Medicine·Mitchell M LevyR Phillip Dellinger
Mar 26, 2015·Medizinische Klinik, Intensivmedizin und Notfallmedizin·G Marx

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Care : the Official Journal of the Critical Care Forum
Guillermo Bugedo, Carlos Romero
British Journal of Anaesthesia
Frank M Brunkhorst, F Schortgen
© 2021 Meta ULC. All rights reserved